NCT07625969 Using Single and Combined Nudge Strategies to Promote Healthier Beverage Intake Among College Students
| NCT ID | NCT07625969 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanjing Medical University |
| Condition | Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2026-07-02 |
| Primary Completion | 2026-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2026-07-02 with a primary completion date of 2026-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of this study was to examine whether three nudging strategies influence beverage consumption behavior among Chinese university students. These interventions included health warning messages, hedonic labeling, and a combination of health warning and hedonic labeling. A between-subjects experimental design with a single factor was employed to assess the effects of these strategies on students' choices between sugar-sweetened and sugar-free beverages, thereby evaluating their effectiveness in promoting healthier beverage selections.
Eligibility Criteria
Inclusion Criteria: * college students * willing to participate Exclusion Criteria: none
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07625969 clinical trial?
This trial is open to participants of all sexes, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07625969 currently recruiting?
Yes, NCT07625969 is actively recruiting participants. Contact the research team at heyuan@njmu.edu.cn for enrollment information.
Where is the NCT07625969 trial being conducted?
This trial is being conducted at Nanjing, China.
Who is sponsoring the NCT07625969 clinical trial?
NCT07625969 is sponsored by Nanjing Medical University. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.